JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs

Not Applicable

Completed

Conditions: Hyperglycemia
Impaired Glucose Tolerance
Obesity
Lifestyle, Healthy
Glucose, High Blood
PreDiabetes
Weight Loss
Prediabetic State
Lifestyle Risk Reduction
Lifestyle, Sedentary

Interventions: Behavioral: Digital Diabetes Prevention Program (dDPP)
Behavioral: Human Coach-based Diabetes Prevention Program (hDPP)

First Posted Date: 2021-09-24

Last Posted Date: 2024-12-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 368

Registration Number: NCT05056376

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Reading Hospital - Tower Health, Reading, Pennsylvania, United States

Single-sided Deafness and Cochlear Implantation

Completed

Conditions: Hearing Loss, Unilateral
Hearing Loss, Sensorineural
Hearing Loss, Cochlear
Labyrinthitis
Hearing Loss, Sudden
Hearing Loss in Left Ear
Hearing Loss
Hearing Loss in Right Ear

Interventions: Device: Cochlear implantation

First Posted Date: 2021-09-22

Last Posted Date: 2023-11-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 78

Registration Number: NCT05052944

Locations: 🇺🇸
Johns Hopkins Bayview, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Suburban, Bethesda, Maryland, United States

and more 2 locations

The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A

Phase 1

Completed

Conditions: Cannabis

Interventions: Drug: CBD 1mg/Kg
Drug: CBD 2mg/Kg
Drug: CBD 4mg/Kg
Drug: Placebo CBD

First Posted Date: 2021-09-20

Last Posted Date: 2023-06-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 21

Registration Number: NCT05049733

Locations: 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Investigating Distress Tolerance in Adults With Tourette Syndrome

Not Applicable

Completed

Conditions: Tic Disorders
Tics
Tourette Syndrome

Interventions: Behavioral: Distress Tolerance Skills Training

First Posted Date: 2021-09-17

Last Posted Date: 2024-06-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 9

Registration Number: NCT05047705

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation

Active, not recruiting

Conditions: Children
Neurologic Injury
Extracorporeal Membrane Oxygenation

First Posted Date: 2021-09-13

Last Posted Date: 2024-03-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 625

Registration Number: NCT05041712

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

and more 8 locations

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Phase 2

Completed

Conditions: Prurigo Nodularis
Pruritus
Chronic Pruritus
Chronic Prurigo
Skin Diseases

Interventions: Drug: Abrocitinib

First Posted Date: 2021-09-09

Last Posted Date: 2023-07-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT05038982

Locations: 🇺🇸
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration

Terminated

Conditions: Wet Macular Degeneration

First Posted Date: 2021-09-09

Last Posted Date: 2022-09-26

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT05038371

Locations: 🇺🇸
Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland, United States

Preventing Anaphylaxis With Acalabrutinib

Phase 2

Completed

Conditions: Food Allergy Peanut
Food Allergy

Interventions: Drug: Acalabrutinib

First Posted Date: 2021-09-09

Last Posted Date: 2023-09-28

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT05038904

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

A National Survey on the Prevalence and Impact of Multiple Pharmacy Use in Specialty Pharmacy

Not Applicable

Conditions: Health Services Accessibility

Interventions: Other: Survey

First Posted Date: 2021-09-05

Last Posted Date: 2024-12-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 800

Registration Number: NCT05035225

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Developing and Pilot Testing a Remote Smoking Cessation Digital Therapeutic for Individuals With Serious Mental Illness

Not Applicable

Not yet recruiting

Conditions: Smoking Cessation

Interventions: Combination Product: LTQ

First Posted Date: 2021-09-01

Last Posted Date: 2024-11-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 25

Registration Number: NCT05031416

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy